# A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377

> **NCT02005991** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 4 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-05212377
- **DRUG:** PF-05212377
- **DRUG:** PF-05212377

## Key facts

- **NCT ID:** NCT02005991
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2014-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005991, "A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02005991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*